Matinas Biopharma Holdings Inc. (MTNB)
NYSE: MTNBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 3:59 PM ET · Delayed 15 min
MTNB stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.73M
- EPS (TTM)
- -$17.55
- Dividend yield
- None
- 52-week range
- 2.27 – 28.95
- Day range
- 2.62 – 2.85
- Volume / Avg
- 135.18K / 405.99K
- Beta
- —
- Shares outstanding
- 979.52K
52-week range
MTNB stock today
On Oct 8, MTNB ended the session at $2.79, adding $0.02 (0.72%), versus the S&P 500's 0.47% decline. Trading was light, with 135.18K shares changing hands, about 33% of the average daily volume. Shares are 90.4% below their 52-week high of $28.95 and 23.2% above the 52-week low of $2.27, near the bottom of the past year's range.
Matinas Biopharma has posted a net loss over the last twelve months (EPS of -$17.55), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Matinas Biopharma
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2017
Matinas Biopharma peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SPRCSciSparc Ltd. | 4.43 | -4.53% | $2.57M | vs MTNB |
| GOVXGeoVax Labs Inc. | 0.2866 | -0.97% | $2.90M | vs MTNB |
| ELABPMGC Holdings Inc. | 3.11 | -2.51% | $2.52M | vs MTNB |
| SILOSilo Pharma Inc. | 1.45 | +0.69% | $2.98M | vs MTNB |
| PRFXPRF Technologies Ltd. | 0.8612 | -1.88% | $3.01M | vs MTNB |
| PPBTPurple Biotech Ltd. ADR | 1.44 | -1.37% | $2.34M | vs MTNB |
| REVBRevelation Biosciences Inc. | 0.7801 | -5.80% | $3.11M | vs MTNB |
| KAPAKairos Pharma Ltd. | 0.9272 | +6.57% | $3.14M | vs MTNB |
Indexes, lists and sector
Matinas Biopharma stock FAQ
What is Matinas Biopharma's stock price today?
MTNB last traded at $2.79 as of Oct 8, 3:59 PM EDT, up 0.72% on the day. Prices are delayed at least 15 minutes.
What is the MTNB 52-week high?
The 52-week high for MTNB is $28.95 and the 52-week low is $2.27. The stock is currently 90.4% below its high.